A specific batch of Ramipril 5mg Capsules is being recalled due to a packaging error that may have resulted in Amlodipine tablets being included instead. This recall affects batch GR164099, with authorities urging patients and pharmacists to check their medication immediately.
The issue stems from a potential production fault, according to Crescent Pharma Limited, the company behind the recalled product. The company stated the recall is a "precautionary step" after discovering the packaging mistake. Both Ramipril and Amlodipine are medications used to manage high blood pressure.
Pharmacies and healthcare professionals have been advised by the MHRA (Medicines and Healthcare products Regulatory Agency) to return any remaining stock of the affected batch to their suppliers. Patients who find their Ramipril 5mg Capsules packaging contains incorrect labelling or blister strips should take the medicine and its accompanying leaflet to their pharmacy or GP practice for guidance.
Read More: 5 Million Brain Tumor Patients Need Radiosurgery But Few Get It
Ramipril is a widely prescribed medication in the UK, used not only for high blood pressure but also for treating heart failure and improving survival rates after a heart attack. This recall underscores the complexities of pharmaceutical packaging and the vigilance required to ensure patient safety.